SAN FRANCISCO, Feb. 16, 2017 -- Researchers associated with five institutes in Australia looked at whether any commercially-available brain training apps actually help with healthy aging, and found that BrainHQ had far and away the most scientific evidence. Their systematic review of the literature has published in the journal Neuropsychological Review.
The authors found that “current evidence supports that at least some commercially available computerized brain training products can assist in promoting healthy brain aging.”
The researchers conducted a literature review and a review of the brain-training marketplace. They identified 18 companies and looked at the scientific claims behind their products. They found that 11 companies had no clinical trials or empirical evidence indicating that they helped with healthy aging.
Seven companies marketing computerized brain exercises had products backed by peer-reviewed clinical trials, with formal cognitive outcome measures for healthy adults aged 50 and older. The researchers excluded trials that lacked peer reviewed papers or control groups. This methodology resulted in 26 studies for review.
After systematic review, the researchers classified the products of the seven companies into three levels. Level I required at least two well-designed randomized controlled trials or quasi-randomized studies, one of which had to be of high quality. Level II required only one well-designed randomized controlled trial of high quality. Level III required only one moderate/poorly designed randomized controlled trials and other methodological approaches (e.g., internal white paper studies).
BrainHQ and CogniFit met the criteria for Level I. BrainHQ had 10 studies, of which 8 were of high quality, while CogniFit had three studies, of which one was high quality. Cogmed, BrainAge 2 and My Brain Trainer were in Level II, each with one high quality study. Dakim and Lumosity were in Level III, each with one study of moderate quality.
“The publication of high quality studies of commercially available programs has really accelerated over the past five years,” said Dr. Ralph Martins, who led the review. “The evidence now supports the notion that the human brain is plastic in later life, and can benefit from properly designed brain training programs.”
The researchers found that only BrainHQ exercises, made by Posit Science, were backed by more than one high quality study, noting that “multiple peer-reviewed articles evaluating Posit Science programs have fulfilled the gold standard for clinical trials.”
”This review helps clinicians separate the wheat from the chaff,” said Dr. Henry Mahncke, CEO of Posit Science. “Finally, there is an independent basis for recommending the program with the most proven efficacy to people concerned about maintaining or improving cognitive performance.”
Some of the exercises in BrainHQ are available for free, either by registering at www.brainhq.com or through a download of the BrainHQ app from the Apple App Store. Full access to the dozens of exercises in BrainHQ is available to annual subscribers for $8 per month. Also, many public libraries offer free access to all the exercises in BrainHQ.
For more information, contact [email protected]


Instagram Outage Disrupts Thousands of U.S. Users
Australian Scandium Project Backed by Richard Friedland Poised to Support U.S. Critical Minerals Stockpile
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
AMD Shares Slide Despite Earnings Beat as Cautious Revenue Outlook Weighs on Stock
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
Anthropic Eyes $350 Billion Valuation as AI Funding and Share Sale Accelerate
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Nintendo Shares Slide After Earnings Miss Raises Switch 2 Margin Concerns
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Ford and Geely Explore Strategic Manufacturing Partnership in Europe 



